Bausch Health Companies Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $157.0M | $-46.0M | $-592.0M | $-225.0M | $-948.0M | $-560.0M | $-1.79B | $-4.14B |
| Depreciation & Amortization | $1.21B | $1.27B | $1.26B | $1.39B | $1.55B | $1.83B | $2.08B | $2.82B |
| Depreciation | $207.0M | $190.0M | $187.0M | $179.0M | $177.0M | $180.0M | $178.0M | $175.0M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $216.0M | $150.0M | $132.0M | $126.0M | $128.0M | $105.0M | $102.0M | $87.0M |
| Net Cash from Operating Activities | $1.40B | $1.60B | $1.03B | $-728.0M | $1.43B | $1.11B | $1.50B | $1.50B |
| Investing Activities | ||||||||
| Capital Expenditures | $397.0M | $337.0M | $215.0M | $218.0M | $269.0M | $302.0M | $270.0M | $157.0M |
| Business Acquisitions | — | — | $1.89B | $45.0M | $0 | $0 | $180.0M | $-5.0M |
| Net Cash from Investing Activities | $-595.0M | $-454.0M | $-2.15B | $-303.0M | $409.0M | $-261.0M | $-419.0M | $-196.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-742.0M | $-868.0M | $1.48B | $-474.0M | $-1.51B | $-2.29B | $1.44B | $-1.35B |
| Net Change in Cash | $124.0M | $239.0M | $371.0M | $-1.53B | $303.0M | $-1.43B | $2.52B | $-74.0M |
| Free Cash Flow | $1.00B | $1.26B | $817.0M | $-946.0M | $1.16B | $809.0M | $1.23B | $1.34B |